MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-15-2026
Vivos Therapeutics EPS Ratio 2011-2026 | VVOS
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Vivos Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.07 | -2.22 | -11.1 | -25.9 | -0.96 | -1.4 | -0.95 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.95 | -25.9 | -6.38 |
Quarterly EPS Ratio Vivos Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.49 | -0.55 | -0.45 | - | -0.4 | -0.6 | -1.63 | - | -1.75 | -4.62 | -1.72 | - | -6.4 | -0.33 | -0.26 | - | -0.26 | -0.19 | -0.19 | - | -0.17 | -0.13 | -0.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.13 | -6.4 | -1.13 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bio-Rad Laboratories
BIO
|
-25.6 | $ 295.96 | - | $ 8.35 B |  USA |
 |
Bruker Corporation
BRKR
|
0.76 | $ 39.48 | - | $ 5.88 K | USA |
 |
Align Technology
ALGN
|
5.63 | $ 186.53 | - | $ 14 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
1.29 | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
-9.65 | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-0.51 | $ 3.52 | - | $ 132 M |  France |
 |
Acutus Medical
AFIB
|
-2.81 | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
-0.52 | $ 12.65 | - | $ 1.71 B | USA |
 |
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-1.69 | $ 17.85 | - | $ 419 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-0.13 | $ 0.59 | - | $ 36.7 M | USA |
 |
LENSAR
LNSR
|
-2.87 | $ 6.25 | - | $ 74.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
1.96 | $ 64.61 | - | $ 95.6 B | USA |
 |
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
-0.94 | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
-39.7 | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
-0.9 | $ 10.46 | - | $ 296 M | USA |
 |
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
0.89 | $ 25.71 | - | $ 217 M | USA |
 |
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
-6.16 | $ 2.74 | - | $ 7.6 M | USA |
 |
Stryker Corporation
SYK
|
2.21 | $ 341.24 | - | $ 130 B | USA |
 |
GBS
GBS
|
-2 | - | -0.57 % | $ 7.12 M | USA |
 |
Tactile Systems Technology
TCMD
|
0.83 | $ 25.35 | - | $ 580 M | USA |
 |
TELA Bio
TELA
|
-0.83 | $ 0.66 | 8.79 % | $ 31 M | USA |
 |
TransMedics Group
TMDX
|
5.6 | $ 116.11 | - | $ 3.95 B | USA |
 |
Tandem Diabetes Care
TNDM
|
-0.01 | $ 20.66 | - | $ 1.41 B | USA |
 |
Globus Medical
GMED
|
3.98 | $ 94.55 | - | $ 12.8 B | USA |
 |
Helius Medical Technologies
HSDT
|
-14.6 | $ 1.94 | - | $ 1.18 M | USA |
 |
Butterfly Network
BFLY
|
-0.34 | $ 4.86 | - | $ 1.03 B | USA |
 |
Inogen
INGN
|
-0.86 | $ 6.2 | - | $ 165 M | USA |
 |
IRIDEX Corporation
IRIX
|
-0.26 | $ 1.04 | - | $ 17.6 M | USA |
 |
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
0.08 | $ 10.99 | - | $ 394 M | USA |
 |
Inspire Medical Systems
INSP
|
4.95 | $ 56.64 | - | $ 1.66 B | USA |
 |
Varex Imaging Corporation
VREX
|
-1.7 | $ 11.78 | - | $ 488 M | USA |